论文信息 - The clinical utility of dynamic ctDNA monitoring in inoperable localized NSCLC patients - 字舞流文

The clinical utility of dynamic ctDNA monitoring in inoperable localized NSCLC patients

Yang Xu | Y. Yang | Y. Shao | Q. Ou | Jianyang Wang | Xin Wang | N. Bi | Linfa Wu | Luhua Wang | Jingbo Wang | Yuqi Wu | Jingjing Zhao | Kunpeng Xu | Xiaotian Zhao | Tao Zhang | Xin Xu | L. Wu | Linfang Wu

[1] B. Yaremko,et al. Exploitation of treatment induced tumor lysis to enhance sensitivity of ctDNA analysis: A first-in-human pilot study. , 2020 .

[2] X. Yi,et al. Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer , 2020, Cell Death & Disease.

[3] S. Shchegrova,et al. Analysis of Plasma Cell-Free DNA by Ultradeep Sequencing in Patients With Stages I to III Colorectal Cancer , 2019, JAMA oncology.

[4] Arnaud Boyer,et al. Durvalumab after chemoradiotherapy in stage III non-small cell lung cancer. , 2018, Journal of thoracic disease.

[5] Publisher's Note , 2018, Anaesthesia.

[6] Ash A. Alizadeh,et al. Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling. , 2017, Cancer discovery.

[7] J. Crowley,et al. The IASLC Lung Cancer Staging Project: External Validation of the Revision of the TNM Stage Groupings in the Eighth Edition of the TNM Classification of Lung Cancer , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[8] B. Han,et al. Capture‐Based Targeted Ultradeep Sequencing in Paired Tissue and Plasma Samples Demonstrates Differential Subclonal ctDNA‐Releasing Capability in Advanced Lung Cancer , 2017, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.